PATENT CLAIM ANALYSIS

Application Number: 15762993
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "236200"]

Abstract:
The present disclosure compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the TEAD transcription factor, and are useful in the treatment of diseases related to the activity of TEAD transcription factor including, e.g., cancer and other diseases.

Claim (Index 89):
A method for detecting a TEAD domain in a cell comprising:\n labeling the cell with a chemical probe to form a labelled cell; lysing the labelled cell; treating the lysed cell with biotin-azide; precipitating proteins of the lysed cell; suspending the precipitated protein in a buffer to form a suspension; enriching the suspension with streptavidin agarose to form protein-bound streptavidin agarose beads; washing the protein-bound streptavidin agarose beads with a suspension buffer; eluting the bound proteins with elution buffer; and processing the eluted proteins with SDS-PAGE sample buffer.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.64516
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12692078', '14795499', '15613379', '14775917', '12813148']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7494879520269825
- 35 USC 102 Novelty (BERT): 0.5223886795206507
- Combined Prediction Score: 0.7267780247763493
- Mean Citation Score: 282.784528
- Max Citation Score: 299.21698
- Similarity Product: 169.0739474265051

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test